<?xml version="1.0" encoding="UTF-8"?>
<p>Different strains of HCoV, including SARS-CoV, can infect different myeloid cells [
 <xref rid="B14-viruses-12-00014" ref-type="bibr">14</xref>,
 <xref rid="B220-viruses-12-00014" ref-type="bibr">220</xref>,
 <xref rid="B252-viruses-12-00014" ref-type="bibr">252</xref>,
 <xref rid="B253-viruses-12-00014" ref-type="bibr">253</xref>,
 <xref rid="B254-viruses-12-00014" ref-type="bibr">254</xref>,
 <xref rid="B255-viruses-12-00014" ref-type="bibr">255</xref>,
 <xref rid="B256-viruses-12-00014" ref-type="bibr">256</xref>] to manipulate the innate immunity and to disseminate to other tissues, including the CNS, where they may be associated with other type of pathologies, especially in immunocompromised individuals as it was observed for murine cytomegalovirus (MCMV) [
 <xref rid="B257-viruses-12-00014" ref-type="bibr">257</xref>,
 <xref rid="B258-viruses-12-00014" ref-type="bibr">258</xref>]. Moreover, persistently-infected leukocytes [
 <xref rid="B252-viruses-12-00014" ref-type="bibr">252</xref>] may serve as a reservoir and vector for neuroinvasive HCoV [
 <xref rid="B245-viruses-12-00014" ref-type="bibr">245</xref>]. Therefore, neuroinvasive HCoV could use the hematogenous route to penetrate into the CNS. 
</p>
